| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443563 | European Journal of Cancer | 2014 | 11 Pages |
Abstract
Neither trabectedin nor doxorubicin-based chemotherapy showed significant superiority in the first-line treatment of patients with advanced translocation-related sarcoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jean-Yves Blay, Michael G. Leahy, Binh Bui Nguyen, Shreyaskumar R. Patel, Peter Hohenberger, Armando Santoro, Arthur P. Staddon, Nicolas Penel, Sophie Piperno-Neumann, Andrew Hendifar, Pilar Lardelli, Antonio Nieto, Vicente Alfaro, Sant P. Chawla,